Adherence to repeat fecal occult blood testing in an urban community health center network

Journal of Community Health

Volumn 38, Issue 5, 2013, Pages 829-833

  Liss, David T ^a   Petit Homme, Anita ^a   Feinglass, Joe ^a   Buchanan, David R ^a,b   Baker, David W ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Erie Family Health Center   (United States)

Author keywords

Adherence; Cancer screening; Colorectal cancer; Disparities; Preventive care

Indexed keywords

AGED; ARTICLE; COLORECTAL TUMOR; EARLY DIAGNOSIS; ETHNOLOGY; FEMALE; HEALTH CENTER; HEALTH SERVICE; HISPANIC; HUMAN; MALE; MEDICALLY UNINSURED; METHODOLOGY; MIDDLE AGED; OCCULT BLOOD; PATIENT COMPLIANCE; RETROSPECTIVE STUDY; STATISTICS; COLORECTAL NEOPLASMS; PROCEDURES; STATISTICS AND NUMERICAL DATA;

AGED; COLORECTAL NEOPLASMS; COMMUNITY HEALTH CENTERS; EARLY DETECTION OF CANCER; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; MEDICALLY UNINSURED; MIDDLE AGED; OCCULT BLOOD; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; URBAN HEALTH SERVICES;

EID: 84884262811     PISSN: 00945145     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10900-013-9685-x     Document Type: Article

References (28)

1. U.S. Preventive Services Task Force. (2008). Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 149(9), 627-637.
2. Zauber, A. G.; Lansdorp-Vogelaar, I.; Knudsen, A. B.; Wilschut, J.; van Ballegooijen, M.; Kuntz, K. M. (2008). Evaluating test strategies for colorectal cancer screening: A decision analysis for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 149(9), 659-669.
3. U.S. Preventive Services Task Force. (2008). Screening for colorectal cancer: Clinical summary of U.S. preventive task force recommendation. http://www.uspreventiveservicestaskforce.org/uspstf08/colocancer/colcancs.pdf. Accessed 28 Jan 2013.
4. Fenton, J. J.; Elmore, J. G.; Buist, D. S.; Reid, R. J.; Tancredi, D. J.; Baldwin, L. M. (2010). Longitudinal adherence with fecal occult blood test screening in community practice. Annals of Family Medicine, 8(5), 397-401.
5. Gellad, Z. F.; Stechuchak, K. M.; Fisher, D. A.; et al. (2011). Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality. American Journal of Gastroenterology, 106(6), 1125-1134.
6. Mandel, J. S.; Bond, J. H.; Church, T. R.; et al. (1993). Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study. New England Journal of Medicine, 328(19), 1365-1371.
7. Kronborg, O.; Fenger, C.; Olsen, J.; Jorgensen, O. D.; Sondergaard, O. (1996). Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet, 348(9040), 1467-1471.
8. Crawford, N. D.; Jones, C. P.; Richardson, L. C. (2010). Understanding racial and ethnic disparities in colorectal cancer screening: Behavioral risk factor surveillance system, 2002 and 2004. Ethnicity and Disease, 20(4), 359-365.
9. Quick, B. W.; Hester, C. M.; Young, K. L.; Greiner, K. A. (2013). Self-reported barriers to colorectal cancer screening in a racially diverse, low-income study population. Journal of Community Health, 38(2), 285-292.
10. Percac-Lima, S.; Aldrich, L. S.; Gamba, G. B.; Bearse, A. M.; Atlas, S. J. (2010). Barriers to follow-up of an abnormal Pap smear in Latina women referred for colposcopy. Journal of General Internal Medicine, 25(11), 1198-1204.
11. Arnold, C. L.; Rademaker, A.; Bailey, S. C.; et al. (2012). Literacy barriers to colorectal cancer screening in community clinics. Journal of Health Communication, 17(Suppl 3), 252-264.
12. Coronado, G.; Thompson, B. (2000). Rural Mexican American men's attitudes and beliefs about cancer screening. Journal of Cancer Education, 15(1), 41-45.
13. Soneji, S.; Iyer, S. S.; Armstrong, K.; Asch, D. A. (2010). Racial disparities in stage-specific colorectal cancer mortality: 1960-2005. American Journal of Public Health, 100(10), 1912-1916.
14. Alexander, D. D.; Waterbor, J.; Hughes, T.; Funkhouser, E.; Grizzle, W.; Manne, U. (2007). African-American and caucasian disparities in colorectal cancer mortality and survival by data source: an epidemiologic review. Cancer Biomarkers, 3(6), 301-313.
15. Wang, A.; Clouston, S. A.; Rubin, M. S.; Colen, C. G.; Link, B. G. (2012). Fundamental causes of colorectal cancer mortality: The implications of informational diffusion. Milbank Quarterly, 90(3), 592-618.
16. Byers, T. (2010). Two decades of declining cancer mortality: Progress with disparity. Annual Review of Public Health, 31, 121-132.
17. The Dartmouth Atlas of Health Care. (2008). List of ICD-9-CM codes by chronic disease category. Nine chronic conditions used in The Dartmouth Atlas of Health Care 2008. http://www.dartmouthatlas.org/downloads/methods/chronic- disease-codes-2008.pdf. Accessed 28 Jan 2013.
18. Zou, G. (2004). A modified poisson regression approach to prospective studies with binary data. American Journal of Epidemiology, 159(7), 702-706.
19. Doubeni, C. A.; Laiyemo, A. O.; Young, A. C.; et al. (2010). Primary care, economic barriers to health care, and use of colorectal cancer screening tests among medicare enrollees over time. Annals of Family Medicine, 8(4), 299-307.
20. Seeff, L. C.; Nadel, M. R.; Klabunde, C. N.; et al. (2004). Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer, 100(10), 2093-2103.
21. Ioannou, G. N.; Chapko, M. K.; Dominitz, J. A. (2003). Predictors of colorectal cancer screening participation in the United States. American Journal of Gastroenterology, 98(9), 2082-2091.
22. Committee on Quality of HealthCare in America. (2001). Crossing the quality chasm: A new health system for the twenty-first century. Washington, DC: Institute of Medicine.
23. Mosen, D. M.; Feldstein, A. C.; Perrin, N.; et al. (2010). Automated telephone calls improved completion of fecal occult blood testing. Medical Care, 48(7), 604-610.
24. Myers, R. E.; Sifri, R.; Hyslop, T.; et al. (2007). A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer, 110(9), 2083-2091.
25. Liles, E. G.; Perrin, N.; Rosales, A. G.; et al. (2012). Change to FIT increased CRC screening rates: evaluation of a U.S. screening outreach program. American Journal of Managed Care, 18(10), 588-595.
26. Federici, A.; Giorgi Rossi, P.; Borgia, P.; Bartolozzi, F.; Farchi, S.; Gausticchi, G. (2005). The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: A cluster randomized controlled trial. Journal of Medical Screening, 12(2), 83-88.
27. Hoffman, R. M.; Steel, S.; Yee, E. F.; Massie, L.; Schrader, R. M.; Murata, G. H. (2010). Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: A randomized, controlled trial. Preventive Medicine, 50(5-6), 297-299.
28. Health Resources and Resources Administration. (2012). Approved uniform data system changes for 2012: Program assistance letter 2012-03. http://bphc.hrsa.gov/policiesregulations/policies/pdfs/pal201203.pdf. Accessed 30 Jan 2013.